L. Kircik
Feb 1, 2013
Citations
0
Influential Citations
3
Citations
Journal
Journal of drugs in dermatology : JDD
Abstract
As the accumulated clinical evidence and experience to be presented in the next several pages demonstrate, the unique engineering of the clocortolone pivalate molecule balances potency with documented efficacy and a favorable safety profile. Clocortolone pivalate 0.1% cream is a well-formulated and versatile therapeutic option to consider for many of our patients with steroid-responsive dermatoses.